Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08BGK
|
||||
Former ID |
DIB020504
|
||||
Drug Name |
N-chloromethyl-brucine
|
||||
Synonyms |
N-chloromethylbrucine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [540379] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H28ClN2O4+
|
||||
InChI |
InChI=1S/C24H28ClN2O4/c1-29-17-8-15-16(9-18(17)30-2)26-21(28)10-19-22-14-7-20-24(15,23(22)26)4-5-27(20,12-25)11-13(14)3-6-31-19/h3,8-9,14,19-20,22-23H,4-7,10-12H2,1-2H3/q+1/t14-,19-,20-,22-,23-,24+,27?/m0/s1
|
||||
InChIKey |
GCEPQLWZBVGLQN-CQIPDZJVSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Muscarinic receptor | Target Info | Modulator (allosteric modulator) | [534573] | |
Muscarinic acetylcholine receptor M3 | Target Info | Modulator (allosteric modulator) | [534573] | ||
KEGG Pathway | Calcium signaling pathway | ||||
cAMP signaling pathway | |||||
Neuroactive ligand-receptor interaction | |||||
PI3K-Akt signaling pathway | |||||
Cholinergic synapse | |||||
Regulation of actin cytoskeletonhsa04020:Calcium signaling pathway | |||||
Regulation of actin cytoskeleton | |||||
Insulin secretion | |||||
Salivary secretion | |||||
Gastric acid secretion | |||||
Pancreatic secretion | |||||
PathWhiz Pathway | Muscle/Heart ContractionPW000565:Gastric Acid Production | ||||
WikiPathways | Monoamine GPCRs | ||||
Calcium Regulation in the Cardiac Cell | |||||
Regulation of Actin Cytoskeleton | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
Secretion of Hydrochloric Acid in Parietal Cells | |||||
GPCR ligand binding | |||||
GPCR downstream signalingWP58:Monoamine GPCRs | |||||
Integration of energy metabolism | |||||
GPCR downstream signaling | |||||
GPCRs, Other | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.